PATENT CLAIM ANALYSIS

Application Number: 15943069
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["514", "04400R"]

Abstract:
Disclosed herein are pharmaceutical compositions and methods for inhibiting oxidative stress in a subject having atrial or ventricular arrhythmias, ventricular failure or heart failure. The methods include administering an effective amount of a NOX2 inhibitor agent to the subject, wherein said administering is under conditions such that a level of oxidative stress in myocardial tissue is reduced or eliminated. The pharmaceutical compositions include a NOX2 inhibitor agent.

Claim (Index 2):
The method of  claim 1 , wherein said arrhythmia comprises atrial fibrillation.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 91.0
- Lexical Diversity: 1.53191
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14542501', '15453947', '14169751', '13890116', '13476412']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7757020599595825
- 35 USC 102 Novelty (BERT): 0.6933425004240028
- Combined Prediction Score: 0.7674661040060246
- Mean Citation Score: 427.02894
- Max Citation Score: 709.133
- Similarity Product: 702.4859939901828

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test